Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125223151 | 12522315 | 1 | I | 20160618 | 20160701 | 20160701 | EXP | CA-VALIDUS PHARMACEUTICALS LLC-CA-2016VAL002188 | VALIDUS | NAUD K, HORNE G, VAN DEN HOF M. A WOMAN WITH MARFAN SYNDROME IN PREGNANCY MANAGING HIGH VASCULAR RISK WITH MULTIDISCIPLINARY CARE. JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA. 2015;37(8):724-7 | 28.00 | YR | F | Y | 0.00000 | 20160701 | MD | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125223151 | 12522315 | 1 | PS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | 12.5 MG, BID | U | 17963 | 12.5 | MG | ||||||||
125223151 | 12522315 | 2 | SS | MAGNESIUM SULFATE. | MAGNESIUM SULFATE | 1 | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125223151 | 12522315 | 1 | Product used for unknown indication |
125223151 | 12522315 | 2 | Drug therapy |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125223151 | 12522315 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125223151 | 12522315 | Maternal exposure during pregnancy | |
125223151 | 12522315 | Premature delivery |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |